Nonetheless, an anti-tumour effect of IL-15 on the immune system has also been hypothesized in experimental trials [67, 68] and the activation of IL-15 is currently of major interest in several clinical Phase I trials [63, 74]. The gene discussed is IL15; the disease is neoplasm.